Patients With Type 2 Diabetes Have an Increased Demand for Pacemaker Treatment: A Comparison With Age- and Sex-Matched Control Subjects From the General Population.

Elina RautioFredrik GadlerSoffia GudbjörnsdottirStefan FranzénLars RydenAnn-Marie SvenssonLinda G Mellbin

Published in: Diabetes care (2020)

The need for PM treatment is higher in patients with type 2 diabetes than in matched population-based control subjects. Age, diabetes duration, and HbA1c seem to be risk factors for PM treatment.

Keyphrases

air pollution
cardiovascular disease
particulate matter
heavy metals
metabolic syndrome
adipose tissue
insulin resistance
weight loss